MNC Kapital Indonesia Tbk vs Merck Tbk. — how do they compare? MNC Kapital Indonesia Tbk trades at Rp50 (market cap 2.13T, 136K 24h volume), while Merck Tbk. trades at Rp3,740 (market cap 1.68T, 22.8K 24h volume). The key difference: MNC Kapital Indonesia Tbk is the larger of the two by market cap, and MNC Kapital Indonesia Tbk is more actively traded (136K versus 22.8K). Which is the better fit depends on your goals.
| BCAP | MERK | |
|---|---|---|
Market Cap | 2.13T | 1.68T |
Volume | 136K | 22.8K |
Lot | 1.36K | 228 |
Turnover | 6.8M | 82.9M |
Average Price | 50 | 3,636.14 |
Value | 6.8M | 82.9M |
Indicative Equilibrium Price | 50 | 3,520 |
Indicative Equilibrium Volume | 1 | 60 |
Trailing returns across standard periods
Latest headlines on both assets
PT MNC Kapital Indonesia Tbk formerly PT Bhakti Capital Indonesia Tbk was established on 15 July 1999, resulting from the restructuring and consolidation of PT Bhakti Investama Tbk, its holding company. At the time it was established, the Company commenced its business activities in the securities sector, among others are financial advisory, brokerage, underwriting, and research and development. In 2003, the Company carried out a business consolidation and transformed into a holding company of several subsidiaries that are engaged in financial services sector, namely PT Bhakti Finance, PT Bhakti Securities, and PT Bhakti Asset Management.
Read more on BCAP →PT Merck Tbk (the Company) is domiciled in Indonesia and located at Jl. TB Simatupang No. 8, Pasar Rebo, East Jakarta, was established in framework of Law No. 1 of 1967 and Law No. 11 of 1970 on foreign capital investment by deed of notary public Eliza Pondaag, SH dated 14 October 1970 No. 29. PT Merck Indonesia is a member of the Merck International Group. The company produces pharmaceutical products with production facility in East Jakarta. It commenced its operation in 1974 in manufacturing medical products, such as Songobian and Neurobion.
Read more on MERK →